[ET Net News Agency, 17 August 2026] Nomura lowered the target price for JD Health (06618) to HKD60 from HKD67 and maintained the "buy" rating.
The research house said it lowers FY26/27F revenue forecasts by 2%/1%. (rc)
The research house said it lowers FY26/27F revenue forecasts by 2%/1%. (rc)